An insight into pleiotropic regulators Agr and Sar: molecular probes paving the new way for antivirulent therapy
Staphylococcus aureus pathogenesis is an intricate process involving a diverse array of
extracellular proteins, biofilm and cell wall components that are coordinately expressed in …
extracellular proteins, biofilm and cell wall components that are coordinately expressed in …
Exploration of Modulated Genetic Circuits Governing Virulence Determinants in Staphylococcus aureus
The expression of virulence genes in the human pathogen Staphylococcus aureus is
strongly influenced by the multiple global regulators. The signal transduction cascade of …
strongly influenced by the multiple global regulators. The signal transduction cascade of …
Antimicrobial and Antibiofilm Potential of Acyclic Amines and Diamines against Multi-Drug Resistant Staphylococcus aureus
G Kaur, P Balamurugan, S Vasudevan… - Frontiers in …, 2017 - frontiersin.org
Multi-drug resistant Staphylococcus aureus (MDRSA) remains a great challenge despite a
decade of research on antimicrobial compounds against their infections. In the present …
decade of research on antimicrobial compounds against their infections. In the present …
[PDF][PDF] Development and validation of thiolactone peptide mimics to antagonize agr-quorum sensing system in Staphylococcus aureus
Staphylococcus aureus variants evolved via a group specific/non-group specific interaction
of a two component system, histidine-kinase receptor, AgrC and autoinducing peptide, AIP …
of a two component system, histidine-kinase receptor, AgrC and autoinducing peptide, AIP …
[PDF][PDF] PROBING THE BROAD-SPECTRUM THERAPEUTIC POTENTIAL OF AIP II MIMICS TO COMBAT LYSOZYME MEDIATED STAPHYLOCOCCAL INVASION ON …
K GURMEET, S MN, VK Ra, M HEMA… - researchgate.net
Objective: Molecular recognition of AIP II mimics as a global inhibitor against the AgrC
variants and to undertake a real-time clinical applications to treat the lysozyme mediated …
variants and to undertake a real-time clinical applications to treat the lysozyme mediated …